Australia's Vitrafy Life Sciences hits record low on interim loss

Vitrafy Life Sciences

06/02/2025 03:08

** Shares of Vitrafy Life Sciences  VFY.AX  fall 6.6% to a
record low of A$1.52
    ** Biomedical firm posts interim loss of A$25.7 mln ($16.15
mln) in its first earnings report since its IPO in late November
vs loss of A$46,709 a year earlier 
    ** Stock posts its biggest intraday pct loss since January
14
    ** Stock down 5.9% YTD, including current session moves 

($1 = 1.5916 Australian dollars)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)
 ((Jasmeenaraislam.shaikh@thomsonreuters.com))